216095265	216095265	CD	B-NP	O
|	|	NNP	I-NP	O
ZSHM	ZSHM	NNP	I-NP	O
|	|	VBD	B-VP	O
79004464	79004464	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
180543	180543	CD	B-NP	O
|	|	CC	I-NP	O
7/26/2000	7/26/2000	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
ACUTE	ACUTE	NNP	I-NP	I-protein
RENAL	RENAL	NNP	I-NP	I-protein
FAILURE	FAILURE	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/9/2000	1/9/2000	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/4/2000	1/4/2000	CD	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
DEHYDRATION	DEHYDRATION	NN	B-NP	O
.	.	.	O	O

OTHER	OTHER	NN	B-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
DIABETES	DIABETES	NNP	I-NP	O
MELLITUS	MELLITUS	NNP	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
HYPERTENSION	HYPERTENSION	NN	I-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
DIASTOLIC	DIASTOLIC	NN	I-NP	O
DYSFUNCTION	DYSFUNCTION	NN	I-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
SLEEP	SLEEP	NN	I-NP	O
APNEA	APNEA	NN	I-NP	O
.	.	.	O	O

5	5	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
CHRONIC	CHRONIC	NNP	I-NP	O
RENAL	RENAL	NNP	I-NP	O
INSUFFICIENCY	INSUFFICIENCY	NNP	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
GOUT	GOUT	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
GASTROESOPHAGEAL	GASTROESOPHAGEAL	NNP	I-NP	O
REFLUX	REFLUX	NNP	I-NP	O
DISEASE	DISEASE	NNP	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
-RRB-	-RRB-	JJ	I-NP	O
ANEMIA	ANEMIA	NN	I-NP	O
OF	OF	IN	B-PP	O
CHRONIC	CHRONIC	NNP	B-NP	O
DISEASE	DISEASE	NNP	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
69	69	CD	I-NP	O
year-old	year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
heart	heart	NN	B-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
preserved	preserve	VBD	B-VP	O
ejection	ejection	NN	B-NP	O
fraction	fraction	NN	I-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
obstructive	obstructive	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
obstructive	obstructive	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
hypertension	hypertension	NN	I-NP	O
who	who	WP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
Torsemide	Torsemide	NN	B-NP	O
dose	dose	NN	I-NP	O
from	from	IN	B-PP	O
100	100	CD	B-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
to	to	TO	B-PP	O
180	180	CD	B-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
was	be	VBD	B-VP	O
subsequently	subsequently	RB	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Zaroxolyn	Zaroxolyn	NN	B-NP	O
two	two	CD	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
felt	feel	VBN	I-VP	O
increasingly	increasingly	RB	I-VP	O
tired	tire	VBN	I-VP	O
and	and	CC	O	O
light	light	NN	B-NP	O
headed	head	VBN	B-VP	O
without	without	IN	B-PP	O
dyspnea	dyspnea	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
a	a	DT	B-NP	O
very	very	RB	I-NP	O
dry	dry	JJ	I-NP	O
mouth	mouth	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
also	also	RB	I-VP	O
noted	note	VBN	I-VP	O
a	a	DT	B-NP	O
decline	decline	NN	I-NP	O
in	in	IN	B-PP	O
urine	urine	NN	B-NP	O
output	output	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
short	short	JJ	I-NP	O
stay	stay	NN	I-NP	O
unit	unit	NN	I-NP	O
on	on	IN	B-PP	O
May	May	NNP	B-NP	O
,	,	,	O	O
2000	2000	CD	B-NP	O
when	when	WRB	B-ADVP	O
her	her	PRP$	B-NP	O
BUN	BUN	NN	I-NP	B-protein
and	and	CC	I-NP	O
creatinine	creatinine	NN	I-NP	O
were	be	VBD	B-VP	O
125	125	CD	B-NP	O
and	and	CC	I-NP	O
4.2	4.2	CD	I-NP	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O

This	This	DT	B-NP	O
compared	compare	VBN	B-PP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
baseline	baseline	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
about	about	IN	B-NP	O
2.0	2.0	CD	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
intravenous	intravenous	JJ	B-NP	O
hydration	hydration	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
continues	continue	VBZ	B-VP	O
to	to	TO	I-VP	O
complain	complain	VB	I-VP	O
of	of	IN	B-PP	O
dizziness	dizziness	NN	B-NP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
sits	sit	VBZ	B-VP	O
up	up	RP	B-PRT	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
has	have	VBZ	B-VP	O
declined	decline	VBN	I-VP	O
from	from	IN	B-PP	O
4.6	4.6	CD	B-NP	O
to	to	TO	B-PP	O
2.1	2.1	CD	B-NP	O
off	off	IN	B-PP	O
all	all	PDT	B-NP	O
her	her	PRP$	I-NP	O
medications	medication	NNS	I-NP	O
and	and	CC	B-PP	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
mild	mild	JJ	I-NP	O
hydration	hydration	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
two	two	CD	I-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Diabetes	Diabetes	NNP	I-NP	O
mellitus	mellitus	NN	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Gastroesophageal	Gastroesophageal	JJ	I-NP	O
reflux	reflux	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Gout	Gout	NNP	I-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Congestive	Congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
secondary	secondary	JJ	I-NP	O
diastolic	diastolic	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
.	.	.	O	O

5	5	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Diverticulosis	Diverticulosis	NNP	I-NP	O
in	in	IN	B-PP	O
1998	1998	CD	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Obstructive	Obstructive	JJ	I-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Hypertension	Hypertension	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Chronic	Chronic	NNP	I-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
baseline	baseline	NN	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
about	about	IN	B-NP	O
2.0	2.0	CD	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Anemia	Anemia	NN	I-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
allergic	allergic	JJ	B-ADJP	O
to	to	TO	B-PP	O
Morphine	Morphine	NN	B-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
married	marry	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
five	five	CD	B-NP	O
children	child	NNS	I-NP	O
and	and	CC	O	O
two	two	CD	B-NP	O
foster	foster	JJ	I-NP	O
children	child	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
quit	quit	VBD	B-VP	O
smoking	smoke	VBG	I-VP	O
around	around	IN	B-PP	O
nine	nine	CD	B-NP	O
years	year	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
uses	use	VBZ	B-VP	O
a	a	DT	B-NP	O
cane	cane	NN	I-NP	O
with	with	IN	B-PP	O
walking	walk	VBG	B-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Physical	Physical	JJ	B-NP	O
examination	examination	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
was	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
chest	chest	NN	B-NP	O
examination	examination	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	O
examination	examination	NN	I-NP	O
was	be	VBD	B-VP	O
muffled	muffle	VBN	I-VP	O
,	,	,	O	O
but	but	CC	O	O
you	you	PRP	B-NP	O
could	could	MD	B-VP	O
hear	hear	VB	I-VP	O
an	an	DT	B-NP	O
S4	S4	NN	I-NP	B-protein
,	,	,	O	O
S1	S1	NN	B-NP	B-protein
and	and	CC	O	O
S2	S2	NN	B-NP	B-protein
with	with	IN	B-PP	O
a	a	DT	B-NP	O
jugular	jugular	JJ	I-NP	O
venous	venous	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
around	around	IN	B-PP	O
7	7	CD	B-NP	O
cm	cm	NN	I-NP	O
,	,	,	O	O
positive	positive	JJ	B-NP	O
hepatojugular	hepatojugular	JJ	I-NP	O
reflux	reflux	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
peripheral	peripheral	JJ	I-NP	O
edema	edema	NN	I-NP	O
of	of	IN	B-PP	O
both	both	DT	B-NP	O
legs	leg	NNS	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
were	be	VBD	B-VP	O
warm	warm	JJ	B-ADJP	O
and	and	CC	O	O
well	well	RB	B-ADJP	O
perfused	perfuse	VBN	I-ADJP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
is	be	VBZ	B-VP	O
obese	obese	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
soft	soft	JJ	I-ADJP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
cyanosis	cyanosis	NN	I-NP	O
or	or	CC	I-NP	O
clubbing	clubbing	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
extremities	extremity	NNS	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
:	:	:	O	O
EKG	EKG	NN	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
,	,	,	O	O
first	first	JJ	B-NP	O
degree	degree	NN	I-NP	O
atrioventricular	atrioventricular	JJ	I-NP	O
block	block	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
heart	heart	NN	I-NP	B-protein
rate	rate	NN	I-NP	I-protein
around	around	IN	B-PP	I-protein
90	90	CD	B-NP	I-protein
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
short	short	JJ	I-NP	O
stay	stay	NN	I-NP	O
unit	unit	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
fluid	fluid	NN	B-NP	O
for	for	IN	B-PP	O
two	two	CD	B-NP	O
days	day	NNS	I-NP	O
and	and	CC	O	O
all	all	DT	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
were	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Cardiology	Cardiology	NNP	I-NP	O
Service	Service	NNP	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
on	on	IN	B-PP	O
April	April	NNP	B-NP	O
,	,	,	O	O
2000	2000	CD	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
inhouse	inhouse	RB	B-ADVP	O
with	with	IN	B-PP	O
that	that	DT	B-NP	O
being	be	VBG	B-VP	O
her	her	PRP$	B-NP	O
fourth	fourth	JJ	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	O
medications	medication	NNS	I-NP	O
were	be	VBD	B-VP	O
progressively	progressively	RB	B-ADJP	O
re-initiated	re-initiated	JJ	I-ADJP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
Imdur	Imdur	NN	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-PP	O
120	120	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
course	course	NN	I-NP	O
is	be	VBZ	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
progressive	progressive	JJ	B-NP	O
decline	decline	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
BUN	BUN	NN	I-NP	B-protein
and	and	CC	I-NP	O
creatinine	creatinine	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
April	April	NNP	B-NP	O
,	,	,	O	O
2000	2000	CD	B-NP	O
we	we	PRP	B-NP	O
restarted	restart	VBD	B-VP	O
her	her	PRP	B-NP	O
Lisinopril	Lisinopril	NNP	I-NP	O
at	at	IN	B-PP	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
came	come	VBD	B-VP	O
in	in	RP	B-PRT	O
on	on	IN	B-PP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
fine	fine	JJ	B-ADJP	O
with	with	IN	B-PP	O
this	this	DT	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
next	next	JJ	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
we	we	PRP	B-NP	O
restarted	restart	VBD	B-VP	O
her	her	PRP$	B-NP	O
Torsemide	Torsemide	NN	I-NP	O
and	and	CC	O	O
increased	increase	VBD	B-VP	O
her	her	PRP$	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Lisinopril	Lisinopril	NNP	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
bump	bump	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
BUN	BUN	NN	I-NP	B-protein
and	and	CC	I-NP	O
creatinine	creatinine	NN	I-NP	O
back	back	RB	B-ADVP	O
up	up	RB	I-ADVP	O
to	to	TO	B-PP	O
around	around	IN	B-NP	O
2.8	2.8	CD	I-NP	O
from	from	IN	B-PP	O
1.9	1.9	CD	B-NP	O
.	.	.	O	O

Because	Because	IN	B-SBAR	O
she	she	PRP	B-NP	O
diuresed	diurese	VBD	B-VP	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
about	about	IN	B-NP	O
300	300	CD	I-NP	O
cc	cc	NN	I-NP	O
that	that	IN	B-NP	O
day	day	NN	B-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
presumed	presume	VBD	B-VP	O
this	this	DT	B-NP	O
bump	bump	NN	I-NP	O
was	be	VBD	B-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-VP	O
increase	increase	VB	I-VP	O
dose	dose	NN	B-NP	O
of	of	IN	B-PP	O
Lisinopril	Lisinopril	NNP	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
decreased	decrease	VBD	B-VP	O
the	the	DT	B-NP	O
dose	dose	NN	I-NP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
and	and	CC	O	O
continued	continue	VBD	B-VP	O
her	her	PRP$	B-NP	O
Torsemide	Torsemide	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
BUN	BUN	NN	I-NP	O
and	and	CC	I-NP	O
creatinine	creatinine	NN	I-NP	O
stabilized	stabilize	VBD	B-VP	O
then	then	RB	B-ADVP	O
at	at	IN	B-PP	O
63	63	CD	B-NP	O
and	and	CC	I-NP	O
2.8	2.8	CD	I-NP	O
.	.	.	O	O

Because	Because	IN	B-PP	O
of	of	IN	I-PP	O
this	this	DT	B-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
Lisinopril	Lisinopril	NNP	B-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
performed	perform	VBD	B-VP	O
a	a	DT	B-NP	O
renal	renal	JJ	I-NP	O
artery	artery	NN	I-NP	O
scan	scan	NN	I-NP	O
with	with	IN	B-PP	O
results	result	NNS	B-NP	O
pending	pende	VBG	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
dictation	dictation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
clearly	clearly	RB	B-ADVP	O
at	at	IN	B-PP	O
her	her	PRP	B-NP	O
driest	dry	JJS	I-NP	O
considering	consider	VBG	B-VP	O
the	the	DT	B-NP	O
medication	medication	NN	I-NP	O
regimen	regimen	NN	I-NP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
clearly	clearly	RB	B-ADJP	O
orthostatic	orthostatic	JJ	I-ADJP	O
this	this	DT	B-NP	O
morning	morning	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
100	100	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
Torsemide	Torsemide	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
with	with	IN	B-PP	O
before	before	IN	B-PP	O
knowledge	knowledge	NN	B-NP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
will	will	MD	B-VP	O
drink	drink	VB	I-VP	O
quite	quite	RB	B-NP	O
a	a	DT	I-NP	O
bit	bit	NN	I-NP	O
more	more	RBR	B-ADVP	O
than	than	IN	B-SBAR	O
she	she	PRP	B-NP	O
does	do	VBZ	B-VP	O
inhouse	inhouse	VB	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
up	up	RP	B-PRT	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
potassium	potassium	NN	I-NP	O
,	,	,	O	O
renal	renal	JJ	B-NP	O
function	function	NN	I-NP	O
and	and	CC	O	O
renal	renal	JJ	B-NP	O
artery	artery	NN	I-NP	O
scan	scan	NN	I-NP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Mel	Mel	NNP	I-NP	O
Minshall	Minshall	NNP	I-NP	O
MEDICATIONS	MEDICATIONS	NNP	I-NP	O
ON	ON	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Albuterol	Albuterol	NNP	I-NP	O
inhaler	inhaler	NN	I-NP	O
2	2	CD	B-NP	O
puffs	puff	NNS	I-NP	O
inhaled	inhale	VBD	B-VP	O
b.i.d.	b.i.d.	RB	B-NP	O
2	2	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Allopurinol	Allopurinol	NNP	I-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Enteric	Enteric	JJ	I-NP	O
coated	coat	VBN	I-NP	O
aspirin	aspirin	NN	I-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Diclofenac	Diclofenac	NN	I-NP	O
sodium	sodium	NN	I-NP	O
two	two	CD	B-NP	O
drop	drop	NN	I-NP	B-protein
o.u.	o.u.	NN	I-NP	I-protein
b.i.d.	b.i.d.	,	O	I-protein
5	5	CD	B-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
Iron	Iron	NNP	I-NP	I-protein
sulfate	sulfate	NN	I-NP	I-protein
300	300	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
t.i.d.	t.i.d.	NN	I-NP	I-protein
6	6	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
Atrovent	Atrovent	NNP	I-NP	I-protein
inhaler	inhaler	NN	I-NP	I-protein
2	2	CD	B-NP	I-protein
puffs	puff	NNS	I-NP	I-protein
inhaled	inhale	VBD	B-VP	O
q.i.d.	q.i.d.	NN	B-NP	O
7	7	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Prinivil	Prinivil	NNP	I-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
8	8	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Pred	Pred	NNP	I-NP	O
Forte	Forte	NNP	I-NP	O
1	1	CD	I-NP	O
%	%	NN	I-NP	O
prednisolone	prednisolone	NN	I-NP	O
one	one	CD	B-NP	O
drop	drop	NN	I-NP	B-DNA
o.s.	o.s.	NN	I-NP	I-DNA
q.i.d.	q.i.d.	NN	I-NP	I-DNA
9	9	CD	I-NP	I-DNA
-RRB-	-RRB-	NNP	I-NP	I-DNA
Humulin	Humulin	NNP	I-NP	I-DNA
70/30	70/30	CD	I-NP	I-DNA
85	85	CD	I-NP	I-DNA
units	unit	NNS	I-NP	I-DNA
subcutaneously	subcutaneously	RB	B-VP	O
q.	q.	VBG	I-VP	O
AM	AM	NN	B-NP	O
,	,	,	O	O
15	15	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
q.	q.	VBP	B-VP	O
PM	PM	NN	B-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Imdur	Imdur	NNP	I-NP	O
120	120	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
11	11	CD	I-NP	O
-RRB-	-RRB-	:	O	O
Torsemide	Torsemide	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Tiazac	Tiazac	NN	I-NP	O
360	360	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

13	13	CD	B-NP	O
-RRB-	-RRB-	SYM	I-NP	O
Flonase	Flonase	NN	I-NP	O
1-2	1-2	CD	B-NP	O
sprays	spray	NNS	I-NP	O
nasally	nasally	RB	B-ADVP	O
q.	q.	VBP	B-VP	O
day	day	NN	B-NP	O
.	.	.	O	O

14	14	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Cyclopentolate	Cyclopentolate	NN	I-NP	O
hydrochloride	hydrochloride	NN	I-NP	O
0.5	0.5	CD	B-NP	O
%	%	NN	I-NP	O
two	two	CD	B-NP	O
drops	drop	VBZ	B-VP	O
o.s.	o.s.	NN	B-NP	O
b.i.d.	b.i.d.	NNP	B-NP	O
15	15	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Alphagan	Alphagan	NNP	I-NP	O
two	two	CD	B-NP	O
drops	drop	NNS	I-NP	O
o.u.	o.u.	RB	B-NP	O
b.i.d.	b.i.d.	RB	I-NP	O
16	16	CD	I-NP	O
-RRB-	-RRB-	SYM	I-NP	O
Atenolol	Atenolol	NN	I-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

17	17	CD	B-NP	O
-RRB-	-RRB-	SYM	I-NP	O
Colchicine	Colchicine	NN	I-NP	O
0.6	0.6	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
with	with	IN	B-PP	O
services	service	NNS	B-NP	O
.	.	.	O	O

CONDITION	CONDITION	NN	B-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
in	in	IN	B-PP	O
good	good	JJ	B-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

FOLLOW-UP	FOLLOW-UP	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
follow-up	follow-up	VB	I-VP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Jerald	Jerald	NNP	I-NP	O
Lotter	Lotter	NNP	I-NP	O
and	and	CC	O	O
Dr.	Dr.	NNP	B-NP	O
Deangelo	Deangelo	NNP	I-NP	O
Zeiss	Zeiss	NNP	I-NP	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
discharged	discharge	VBN	I-VP	O
with	with	IN	B-PP	O
VNA	VNA	NN	B-NP	O
services	service	NNS	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
blood	blood	NN	I-NP	O
draw	draw	NN	I-NP	O
this	this	DT	B-NP	O
come	come	VB	B-VP	O
Friday	Friday	NNP	B-NP	O
and	and	CC	I-NP	O
Monday	Monday	NNP	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
chem-7	chem-7	NN	I-NP	O
with	with	IN	B-PP	O
results	result	NNS	B-NP	O
forwarded	forward	VBN	B-VP	O
to	to	TO	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Alexander	Alexander	NNP	I-NP	O
Nimmons	Nimmons	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
CARSON	CARSON	NNP	B-NP	O
FINNILA	FINNILA	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
LA93	LA93	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
DOMINICK	DOMINICK	NNP	B-NP	O
J.	J.	NNP	I-NP	O
GEHLBACH	GEHLBACH	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
AD2	AD2	NNP	I-NP	O
RP703/7849	RP703/7849	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
65782	65782	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

GOLZ7N5BR8	GOLZ7N5BR8	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
5/14	5/14	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
5/14	5/14	CD	B-NP	O
CC	CC	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

BUFORD	BUFORD	NNP	B-NP	O
VISCARRA	VISCARRA	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
NX25	NX25	NNP	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

MOHAMMAD	MOHAMMAD	NNP	B-NP	O
L.	L.	NNP	I-NP	O
GANGLUFF	GANGLUFF	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
GI4	GI4	.	O	B-DNA

